Pivalpen

Array
(
    [ID] => 18959
    [post_author] => 17
    [post_date] => 2021-04-30 22:05:13
    [post_date_gmt] => 2021-05-01 01:05:13
    [post_content] => 
Forma Farmacéutica
Comprimidos Recubiertos.
Composición
Cada comprimido recubierto contiene:

Pimavanserina 34 mg (como Pimavanserina Tartrato 40 mg).
Acción Terapéutica
Antipsicótico (código ATC: N05AX17)
Indicaciones
Pivalpen está indicado para el tratamiento de las alucinaciones y delirios asociados con la psicosis de la enfermedad de Parkinson
Presentación
Envases por 30 comprimidos recubiertos redondos color blanco
    [post_title] => Pivalpen
    [post_excerpt] => 
    [post_status] => publish
    [comment_status] => closed
    [ping_status] => closed
    [post_password] => 
    [post_name] => pivalpen
    [to_ping] => 
    [pinged] => 
    [post_modified] => 2021-06-14 14:11:33
    [post_modified_gmt] => 2021-06-14 17:11:33
    [post_content_filtered] => 
    [post_parent] => 0
    [guid] => https://www.bago.com.ar/vademecum/?post_type=productos&p=18959
    [menu_order] => 0
    [post_type] => productos
    [post_mime_type] => 
    [comment_count] => 0
    [filter] => raw
    [prospecto_para_pacientes] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 19032
                    [post_author] => 17
                    [post_date] => 2021-06-14 14:10:27
                    [post_date_gmt] => 2021-06-14 17:10:27
                    [post_content] => 
                    [post_title] => Info Paciente Pivalpen-jun2021
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => info-paciente-pivalpen-jun2021
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2021-06-14 14:10:27
                    [post_modified_gmt] => 2021-06-14 17:10:27
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://www.bago.com.ar/vademecum/wp-content/uploads/2021/06/Info-Paciente-Pivalpen-jun2021.pdf
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => application/pdf
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [url_para_mayor_informacion_video] => 
    [url_para_mayor_informacion] => 
    [url_productos_consumo_masivo] => 
    [prospecto] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 19031
                    [post_author] => 17
                    [post_date] => 2021-06-14 12:58:28
                    [post_date_gmt] => 2021-06-14 15:58:28
                    [post_content] => 
                    [post_title] => Prospecto Pivalpen-jun2021
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => prospecto-pivalpen-jun2021
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2021-06-14 12:58:28
                    [post_modified_gmt] => 2021-06-14 15:58:28
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://www.bago.com.ar/vademecum/wp-content/uploads/2021/06/Prospecto-Pivalpen-jun2021.pdf
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => application/pdf
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [presentacion_img] => Array
        (
        )

    [logo_img] => Array
        (
        )

    [foto_producto] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 18988
                    [post_author] => 17
                    [post_date] => 2021-04-28 16:07:47
                    [post_date_gmt] => 2021-04-28 19:07:47
                    [post_content] => 
                    [post_title] => pivalpen-banner
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => pivalpen-banner
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2021-04-28 16:07:47
                    [post_modified_gmt] => 2021-04-28 19:07:47
                    [post_content_filtered] => 
                    [post_parent] => 18959
                    [guid] => https://www.bago.com.ar/vademecum/wp-content/uploads/2021/02/pivalpen-banner.png
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => image/png
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [fotos_lanzamiento] => Array
        (
        )

    [especialidad] => Array
        (
        )

    [marca] => Array
        (
            [0] => Pivalpen
        )

    [principio_activo] => Array
        (
            [0] => Pimavanserina
        )

    [post_content_formatted] => 
Forma Farmacéutica
Comprimidos Recubiertos.
Composición
Cada comprimido recubierto contiene:
Pimavanserina 34 mg (como Pimavanserina Tartrato 40 mg).
Acción Terapéutica
Antipsicótico (código ATC: N05AX17)
Indicaciones
Pivalpen está indicado para el tratamiento de las alucinaciones y delirios asociados con la psicosis de la enfermedad de Parkinson
Presentación
Envases por 30 comprimidos recubiertos redondos color blanco

)

Array
(
    [_wp_attached_file] => Array
        (
            [0] => prospectos/Prospecto-Pivalpen-jun2021.pdf
        )

    [_wp_attachment_metadata] => Array
        (
            [0] => a:1:{s:5:"sizes";a:4:{s:4:"full";a:4:{s:4:"file";s:34:"Prospecto-Pivalpen-jun2021-pdf.jpg";s:5:"width";i:1088;s:6:"height";i:10753;s:9:"mime-type";s:10:"image/jpeg";}s:6:"medium";a:4:{s:4:"file";s:41:"Prospecto-Pivalpen-jun2021-pdf-30x300.jpg";s:5:"width";i:30;s:6:"height";i:300;s:9:"mime-type";s:10:"image/jpeg";}s:5:"large";a:4:{s:4:"file";s:43:"Prospecto-Pivalpen-jun2021-pdf-104x1024.jpg";s:5:"width";i:104;s:6:"height";i:1024;s:9:"mime-type";s:10:"image/jpeg";}s:9:"thumbnail";a:4:{s:4:"file";s:41:"Prospecto-Pivalpen-jun2021-pdf-15x150.jpg";s:5:"width";i:15;s:6:"height";i:150;s:9:"mime-type";s:10:"image/jpeg";}}}
        )

)

Array
(
    [_wp_attached_file] => Array
        (
            [0] => 2021/06/Info-Paciente-Pivalpen-jun2021.pdf
        )

    [_wp_attachment_metadata] => Array
        (
            [0] => a:1:{s:5:"sizes";a:4:{s:4:"full";a:4:{s:4:"file";s:38:"Info-Paciente-Pivalpen-jun2021-pdf.jpg";s:5:"width";i:1088;s:6:"height";i:3931;s:9:"mime-type";s:10:"image/jpeg";}s:6:"medium";a:4:{s:4:"file";s:45:"Info-Paciente-Pivalpen-jun2021-pdf-83x300.jpg";s:5:"width";i:83;s:6:"height";i:300;s:9:"mime-type";s:10:"image/jpeg";}s:5:"large";a:4:{s:4:"file";s:47:"Info-Paciente-Pivalpen-jun2021-pdf-283x1024.jpg";s:5:"width";i:283;s:6:"height";i:1024;s:9:"mime-type";s:10:"image/jpeg";}s:9:"thumbnail";a:4:{s:4:"file";s:45:"Info-Paciente-Pivalpen-jun2021-pdf-42x150.jpg";s:5:"width";i:42;s:6:"height";i:150;s:9:"mime-type";s:10:"image/jpeg";}}}
        )

)

anexo_congre_single